Total Voting Rights

GlaxoSmithKline PLC
15 December 2006




                GlaxoSmithKline plc - Voting Rights and Capital


In conformity with the Transparency Directive's transitional provision 6 we
hereby notify the market of the following:

GlaxoSmithKline plc's (GSK) issued share capital consists of 5,991,369,750
ordinary shares with voting rights, 232,697,678 ordinary shares of which are
held in Treasury.

Therefore, the total number of voting rights in GSK is 5,758,672,072.

The above figure (5,758,672,072) may be used by shareholders as the denominator
for the calculations by which they can determine if they are required to notify
their interest in, or a change to their interest in GSK under the Financial
Services Authority's Disclosure and Transparency Rules.



S M Bicknell
Company Secretary


15 December 2006


                      This information is provided by RNS
            The company news service from the London Stock Exchange